Assistant Professor, Department of Medicine and Community Health Sciences
Cumming School of Medicine
University of Calgary
Calgary, Alberta

Dr. Glen Hazlewood is a rheumatologist and clinician scientist. He completed his rheumatology training in 2010 at the University of Calgary and his PhD in clinical epidemiology through the University of Toronto in 2016. He is currently an Assistant Professor in the Department of Medicine in Calgary.

Dr. Hazlewood’s program of research is focused on understanding how to align treatment choices in rheumatoid arthritis and other chronic immune-mediated diseases with both best evidence and patients’ preferences.

He chairs the Guidelines Committee through the Canadian Rheumatology Association and is leading the Canadian Rheumatoid Arthritis Guidelines. His research has been published in top-tier medical journals including BMJ, Annals of Rheumatic Diseases and Gastroenterology. His research areas of interest include network meta-analyses, patient preference research, clinical practice guidelines, decision tools, and randomized controlled trials. He is a CIHR New Investigator and to date has received over $1M in CIHR funding, including recent funding to conduct a multi-centre pragmatic randomized trial of drug reduction in patients with rheumatoid arthritis.